| Primary |
| Drug Use For Unknown Indication |
15.1% |
| Product Used For Unknown Indication |
11.5% |
| Hypertension |
11.3% |
| Bronchitis |
8.8% |
| Pneumonia |
6.4% |
| Upper Respiratory Tract Inflammation |
5.4% |
| Urinary Tract Infection |
5.1% |
| Pharyngitis |
4.1% |
| Nasopharyngitis |
3.9% |
| Diabetes Mellitus |
3.6% |
| Gastritis |
3.4% |
| Insomnia |
3.3% |
| Pyrexia |
3.2% |
| Cystitis |
2.7% |
| Constipation |
2.6% |
| Cerebral Infarction |
2.2% |
| Reflux Oesophagitis |
1.9% |
| Infection Prophylaxis |
1.8% |
| Cardiac Failure |
1.8% |
| Ill-defined Disorder |
1.8% |
|
| Interstitial Lung Disease |
16.2% |
| Pneumonia |
8.1% |
| Liver Disorder |
7.3% |
| Toxic Epidermal Necrolysis |
6.8% |
| Pyrexia |
6.4% |
| Hypoglycaemia |
6.0% |
| Altered State Of Consciousness |
4.7% |
| Renal Impairment |
4.3% |
| Urticaria |
4.3% |
| Hyponatraemia |
3.8% |
| Pseudomembranous Colitis |
3.8% |
| Shock |
3.8% |
| Vomiting |
3.8% |
| Hepatic Function Abnormal |
3.4% |
| Drug Eruption |
3.0% |
| Palpitations |
3.0% |
| Respiratory Failure |
3.0% |
| Somnolence |
3.0% |
| Dyspnoea |
2.6% |
| Eosinophilic Pneumonia |
2.6% |
|
| Secondary |
| Pneumonia |
11.7% |
| Drug Use For Unknown Indication |
11.5% |
| Hypertension |
9.8% |
| Product Used For Unknown Indication |
9.2% |
| Bronchitis |
5.8% |
| Pyrexia |
5.3% |
| Urinary Tract Infection |
5.0% |
| Infection Prophylaxis |
4.0% |
| Rheumatoid Arthritis |
3.9% |
| Gastritis |
3.8% |
| Insomnia |
3.6% |
| Nasopharyngitis |
3.5% |
| Pharyngitis |
3.5% |
| Diabetes Mellitus |
3.4% |
| Prophylaxis |
3.4% |
| Gastric Ulcer |
2.7% |
| Myocardial Infarction |
2.6% |
| Upper Respiratory Tract Inflammation |
2.5% |
| Infection |
2.4% |
| Cystitis |
2.3% |
|
| Interstitial Lung Disease |
15.3% |
| Oxygen Saturation Decreased |
9.3% |
| Renal Impairment |
8.9% |
| Pyrexia |
6.4% |
| Respiratory Failure |
6.4% |
| Liver Disorder |
5.9% |
| Pneumonia |
5.5% |
| Rhabdomyolysis |
4.7% |
| Convulsion |
3.8% |
| Muscular Weakness |
3.8% |
| Stomatitis |
3.8% |
| Hypoglycaemia |
3.4% |
| Toxic Epidermal Necrolysis |
3.4% |
| Hepatic Function Abnormal |
3.0% |
| Rash |
3.0% |
| Stevens-johnson Syndrome |
3.0% |
| White Blood Cell Count Increased |
3.0% |
| Platelet Count Decreased |
2.5% |
| Respiratory Arrest |
2.5% |
| Septic Shock |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
31.1% |
| Prophylaxis |
14.2% |
| Drug Use For Unknown Indication |
12.8% |
| Infection Prophylaxis |
4.7% |
| Hypertension |
4.2% |
| Pneumonia |
3.3% |
| Gastritis |
3.1% |
| Constipation |
2.8% |
| Insomnia |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Stem Cell Transplant |
2.3% |
| Pyrexia |
2.3% |
| Multiple Myeloma |
2.0% |
| Diabetes Mellitus |
2.0% |
| Myelodysplastic Syndrome |
2.0% |
| Plasma Cell Myeloma |
2.0% |
| Immunosuppression |
1.6% |
| Chronic Hepatitis C |
1.6% |
| Crohn's Disease |
1.5% |
| Behcet's Syndrome |
1.4% |
|
| White Blood Cell Count Decreased |
19.7% |
| Pneumonia |
9.5% |
| Pyrexia |
7.9% |
| Sepsis |
7.2% |
| Interstitial Lung Disease |
7.0% |
| Thrombocytopenia |
5.1% |
| Vomiting |
4.8% |
| Febrile Neutropenia |
4.5% |
| Platelet Count Decreased |
4.5% |
| Rash |
4.3% |
| Renal Impairment |
4.3% |
| White Blood Cell Count Increased |
3.3% |
| Stomatitis |
3.0% |
| Respiratory Failure |
2.5% |
| Liver Disorder |
2.4% |
| Hyponatraemia |
2.2% |
| Hepatic Function Abnormal |
2.1% |
| Neutrophil Count Decreased |
1.9% |
| Pleural Effusion |
1.9% |
| Shock |
1.9% |
|
